Compounds of {HEAD ~ Formula} I ##STR1## are disclosed as inhibitors having activity against the aspartyl proteases, plasmepsin and cathepsin D. The compounds are therefore useful for treatment of diseases such as malaria and {TAIL ~ Alzheimers disease} 
Compounds of { HEAD ~ Formula } I # # STR1 # # are disclosed as inhibitors having activity against the aspartyl proteases , plasmepsin and cathepsin D. The compounds are therefore useful for treatment of diseases such as malaria and { TAIL ~ Alzheimers disease }
OTH OTH HEAD HEAD HEAD HEAD HEAD OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH TAIL TAIL TAIL TAIL TAIL TAIL